PHARMA DEGEE
0543.470.412 · rovalta.com · 23/09/2026
ACTIVE
PHARMA DEGEE
Financial year 2025 · closed on 31/12/2025
Net result
3,1 k €
-60.3% YoY
Gross margin
534 k €
+14.0% YoY
Equity
292,4 k €
+1.1% YoY
Workforce
4,6 ETP
+12.2% YoY
Overview
What does PHARMA DEGEE do?
PHARMA DEGEE is a Private limited company incorporated in 2013. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Andenne. It employs on average 4,6 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0543.470.412
Incorporation
19/12/2013
Legal form
Private limited company
Registered office
Rue Brun 2
5300 Andenne · WallonieSee on map
5300 Andenne · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
4,6 ETP
Activities (NACE)
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||
| Gross margin | 534 k € | +14.0% | 468,6 k € | +2.1% | 458,8 k € | +12.0% | 409,5 k € | +11.5% | 367,1 k € | -21.2% | 465,6 k € | +10.0% | 423,2 k € | +766% | 48,9 k € | -27.4% | 67,3 k € | +15.9% | 58,1 k € | -25.8% | 78,3 k € | +123% | 35,2 k € |
| EBITDA | 235,2 k € | +20.6% | 195 k € | -13.6% | 225,6 k € | +16.3% | 194 k € | +27.0% | 152,7 k € | -40.9% | 258,3 k € | +22.8% | 210,4 k € | +330% | 48,9 k € | -27.4% | 67,3 k € | +15.9% | 58,1 k € | -25.8% | 78,3 k € | +123% | 35,2 k € |
| Operating result | 54,1 k € | -12.7% | 62 k € | -34.6% | 94,9 k € | +44.5% | 65,7 k € | +161% | 25,2 k € | -80.8% | 130,9 k € | +59.9% | 81,9 k € | +121% | 37,1 k € | -33.2% | 55,5 k € | +20.2% | 46,2 k € | -30.4% | 66,4 k € | +205% | 21,8 k € |
| Net result | 3,1 k € | -60.3% | 7,8 k € | -78.6% | 36,6 k € | +156% | 14,3 k € | +139% | -36,8 k € | -166% | 55,5 k € | +119% | 25,4 k € | +389% | 5,2 k € | -65.7% | 15,1 k € | +49.0% | 10,1 k € | -83.8% | 62,7 k € | -59.7% | 155,6 k € |
| Balance sheet | |||||||||||||||||||||||
| Equity | 292,4 k € | +1.1% | 289,3 k € | +2.8% | 281,4 k € | +15.0% | 244,8 k € | +16.4% | 210,3 k € | -14.9% | 247,1 k € | -27.7% | 341,6 k € | +27.8% | 267,4 k € | +2.0% | 262,2 k € | +6.1% | 247,1 k € | +4.3% | 236,9 k € | +36.0% | 174,2 k € |
| Total assets | 1 M € | -11.4% | 1,2 M € | -6.4% | 1,2 M € | -2.4% | 1,3 M € | -10.3% | 1,4 M € | -6.2% | 1,5 M € | -4.2% | 1,6 M € | +20.6% | 1,3 M € | -3.3% | 1,3 M € | -2.0% | 1,4 M € | -9.1% | 1,5 M € | -6.7% | 1,6 M € |
| Cash | 110,1 k € | -14.0% | 128 k € | -25.0% | 170,7 k € | +44.2% | 118,4 k € | -6.7% | 126,8 k € | +75.6% | 72,2 k € | -24.5% | 95,7 k € | +670425% | 14,3 € | -99.7% | 4,7 k € | +2288% | 197,8 € | -39.7% | 328 € | +2211% | 14,2 € |
| Debts | 734,5 k € | -15.5% | 869,5 k € | -9.0% | 955,4 k € | -6.6% | 1 M € | -15.0% | 1,2 M € | -4.5% | 1,3 M € | +2.3% | 1,2 M € | +18.7% | 1 M € | -4.6% | 1,1 M € | -3.8% | 1,1 M € | -11.5% | 1,3 M € | -11.9% | 1,4 M € |
| Other | |||||||||||||||||||||||
| Workforce | 4,6 ETP | +12.2% | 4,1 ETP | +17.1% | 3,5 ETP | -2.8% | 3,6 ETP | -5.3% | 3,8 ETP | -5.0% | 4,0 ETP | -18.4% | 4,9 ETP | – | – | – | – | – | |||||
Estimate
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 4 ended
Active mandates
THIERRY SANDRONT
ActiveVirginie SANDRONT
ActiveEnded mandates
THIERRY SANDRONT
EndedTHIERRY SANDRONT
EndedVirginie SANDRONT
EndedVirginie SANDRONT
EndedFinancials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 02/07/2025 | 04/07/2024 | 01/09/2023 | 13/07/2022 | 01/07/2021 |
| General meeting | 28/05/2026 | 30/05/2025 | 30/05/2024 | 25/05/2023 | 27/05/2022 | 27/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
13 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 28/05/2026 | 01/07/2026 | French | |
| Abridged model | 31/12/2024 | 30/05/2025 | 02/07/2025 | French | |
| Abridged model | 31/12/2023 | 30/05/2024 | 04/07/2024 | French | |
| Abridged modelCorrection | 31/12/2022 | 25/05/2023 | 01/09/2023 | French | |
| Abridged model | 31/12/2022 | 25/05/2023 | 05/07/2023 | French | |
| Abridged model | 31/12/2021 | 27/05/2022 | 13/07/2022 | French | |
| Abridged model | 31/12/2020 | 27/05/2021 | 01/07/2021 | French | |
| Abridged model | 31/12/2019 | 28/05/2020 | 02/09/2020 | French | |
| Abridged model | 31/12/2018 | 31/05/2019 | 17/06/2019 | French | |
| Abridged model | 31/12/2017 | 31/05/2018 | 16/07/2018 | French | |
| Abridged model | 31/12/2016 | 26/05/2017 | 19/07/2017 | French | |
| Abridged model | 31/12/2015 | 26/05/2016 | 29/08/2016 | French | |
| Abridged model | 31/12/2014 | 28/05/2015 | 10/08/2015 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 4 ended
Active mandates
THIERRY SANDRONT
ActiveVirginie SANDRONT
ActiveEnded mandates
THIERRY SANDRONT
EndedTHIERRY SANDRONT
EndedVirginie SANDRONT
EndedVirginie SANDRONT
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates28/09/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Restructuring05/02/2019DENOMINATION - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring05/11/2018RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Other02/04/2014DIVERS
- Other23/12/2013RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20253,1 k €↓
- 2025Name changePHARMA DEGEE (DEGEE-SANDRONT)
- 2024Annual accounts 20247,8 k €↓
- 2023Annual accounts 202336,6 k €↑
- 2022Annual accounts 202214,3 k €↑
- 2021Annual accounts 2021-36,8 k €↓
- 2020Annual accounts 202055,5 k €↑
- 2019Annual accounts 201925,4 k €↑
- 2018Annual accounts 20185,2 k €↓
- 2018Name changePHARMA DEGEE
- 2017Annual accounts 201715,1 k €↑
- 2016Annual accounts 201610,1 k €↓
- 2015Annual accounts 201562,7 k €↓
- 2014Annual accounts 2014155,6 k €
- 2014Name changeDEGEE-SANDRONT
- 19/12/2013IncorporationPrivate limited company